New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Assertio Holdings, Inc.
ASRT
Shape
US Flag

NASDAQ

107M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

107M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

1.12USD
Shape0.01 ( 0.90%)
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-58%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

56%

Quote Panel

Shape
Updated October 15, 2024
1W 2.75 % 1M -9.68 % 3M -36.00 % 1Y -53.53 %

Key Metrics

Shape
  • Market Cap

    106.78M


  • Shares Outstanding

    95.34M


  • Share in Float

    88.98M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    1.12


  • Average Volume

    676648


  • Beta

    0.797


  • Range

    0.73-2.53


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.assertiotx.com


  • Sector

    Healthcare


Fundamentals

Shape

9.33x

P/E Ratio

0.80x

P/S Ratio

0.80x

P/B Ratio

0.3

Debt/Equity

-261.1%

Net Margin

$-4.8

EPS

How ASRT compares to sector?

P/E Ratio

Relative Strength

Shape

ASRT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$127M

Shape309%

2025-Revenue

$0.06

Shape-61%

2025-EPS

$39M

Shape671%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-07-03

Now: Buy

Alliance Global Partners

initialise

Previous: Not converted

2024-05-28

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

0.08
vs 0.08

Q4.22

arrow
arrow

+1240%

1.34
vs 0.1

Q1.23

arrow
arrow

N/A

-0.07
vs 0.2

Q2.23

arrow
arrow

-19%

0.13
vs 0.16

Q3.23

arrow
arrow

-87%

0.01
vs 0.08

Q4.23

arrow
arrow

-92%

0.11
vs 1.34

Q1.24

arrow
arrow

+157%

0.04
vs -0.07

Q2.24

arrow
arrow

N/A

-0.04
vs 0.13

Q3.24

arrow
arrow

N/A

-0.04
vs 0.01

Q4.24

arrow
arrow

N/A

-0.05
vs 0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+34%

34.2M  vs 25.5M

Q4.22

arrow
arrow

+51%

50.4M  vs 33.3M

Q1.23

arrow
arrow

+16%

42.5M  vs 36.5M

Q2.23

arrow
arrow

+17%

41M  vs 35.1M

Q3.23

arrow
arrow

+4%

35.6M  vs 34.2M

Q4.23

arrow
arrow

-34%

33M  vs 50.4M

Q1.24

arrow
arrow

-24%

32.4M  vs 42.5M

Q2.24

arrow
arrow

-24%

31.1M  vs 41M

Q3.24

arrow
arrow

-19%

28.9M  vs 35.6M

Q4.24

arrow
arrow

-11%

29.3M  vs 33M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.06

Q4.22

arrow
arrow

+39%

0.39
vs 0.03

Q1.23

arrow
arrow

-1%

-0.01
vs 0.39

Q2.23

arrow
arrow

+3%

0.03
vs -0.01

Q3.23

arrow
arrow

-145%

-1.45
vs 0.03

Q4.23

arrow
arrow

-42%

-0.42
vs -1.45

Q1.24

arrow
arrow

-3%

-0.03
vs -0.42

Q2.24

arrow
arrow

-3%

-0.03
vs -0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

76

76
vs 63

21%

Q4.22

arrow
arrow

92

92
vs 76

21%

Q1.23

arrow
arrow

126

126
vs 92

37%

Q2.23

arrow
arrow

156

156
vs 126

24%

Q3.23

arrow
arrow

155

155
vs 156

-1%

Q4.23

arrow
arrow

124

124
vs 155

-20%

Q1.24

arrow
arrow

108

108
vs 124

-13%

Q2.24

arrow
arrow

106

106
vs 108

-2%

Earnings Growth

Latest News